Below are the most recent publications written about "Consumer Product Safety" by people in Profiles.
-
McGregor AJ, Barr H, Greenberg MR, Safdar B, Wildgoose P, Wright DW, Hollander JE. Gender-specific Regulatory Challenges to Product Approval: a panel discussion. Acad Emerg Med. 2014 Dec; 21(12):1334-8.
-
Devaiah A, Jacobowitz O, Siegel G, Shah UK. Practitioners need corporate compliance education: AAO-HNS survey results. Otolaryngol Head Neck Surg. 2010 Feb; 142(2):160-3.
-
John R, Boyle A, Pagani F, Miller L. Physiologic and pathologic changes in patients with continuous-flow ventricular assist devices. J Cardiovasc Transl Res. 2009 Jun; 2(2):154-8.
-
Fischer RA. Prevent fires when using oxygen cylinder regulators. Nursing. 2007 Jan; 37(1):20.
-
Hayes NM, Chidekel A. Pediatric choking. Del Med J. 2004 Sep; 76(9):335-40.
-
Nakamura SW, Pollack-Nelson C, Chidekel AS. Suction-type suffocation incidents in infants and toddlers. Pediatrics. 2003 Jan; 111(1):e12-6.
-
Doranz BJ, Filion LG, Diaz-Mitoma F, Sitar DS, Sahai J, Baribaud F, Orsini MJ, Benovic JL, Cameron W, Doms RW. Safe use of the CXCR4 inhibitor ALX40-4C in humans. AIDS Res Hum Retroviruses. 2001 Apr 10; 17(6):475-86.
-
Jaffee EM, Hruban RH, Biedrzycki B, Laheru D, Schepers K, Sauter PR, Goemann M, Coleman J, Grochow L, Donehower RC, Lillemoe KD, O'Reilly S, Abrams RA, Pardoll DM, Cameron JL, Yeo CJ. Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation. J Clin Oncol. 2001 Jan 01; 19(1):145-56.
-
Shenep JL, Flynn PM, Baker DK, Hetherington SV, Hudson MM, Hughes WT, Patrick CC, Roberson PK, Sandlund JT, Santana VM, Sixbey JW, Slobod KS. Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer. Clin Infect Dis. 2001 Jan; 32(1):36-43.
-
Fish JE, Karpel JP, Craig TJ, Bensch GW, Noonan M, Webb DR, Silverman B, Schenkel EJ, Rooklin AR, Ramsdell JW, Nathan R, Leflein JG, Grossman J, Graft DF, Gower RG, Garay SM, Frigas E, Degraff AC, Bronsky EA, Bernstein DI, Berger W, Shneyer L, Nolop KB, Harrison JE. Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma. J Allergy Clin Immunol. 2000 Nov; 106(5):852-60.